About This Study
Multiple myeloma is a type of blood cancer. The purpose of this study is to find out if the study drug ABBV-383 can be safely used with other treatments for this type of cancer. We want to find out the safest dose of the study drug when combined with these treatments. We also want to see if these combinations help patients whose cancer has returned or didn't respond to previous treatments.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- Review of Medical History
- Physical Examinations
- Phone Calls and/or Emails
- Study Visits and Consultations
- Surveys/Questionnaires
- Laboratory and Imaging Tests
- Specimen Sample Collection
- Diary/e-Diary Writing or Recordings
Age & Gender
- 18 - 100 years old
- All Genders
Language
- This study enrolls English and Spanish speakers
Additional Study Information
- No compensation provided
- Reimbursement offered
Study Locations
- Greater Charlotte, NC